Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Morozowich

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Pharmaceutical Sciences|September 1, 1973
Detection of prostaglandin F2 alpha as pentafluorobenzyl ester by electron-capture GLCJ A Wickramasinghe, W Morozowich, W E Hamlin, et al.
Journal of Theoretical Biology|September 7, 1976
A physical model for the simultaneous membrane transport and metabolism of drugsN F Ho, J Park, W Morozowich, et al.
Journal of Pharmaceutical Sciences|July 1, 1979
Prostaglandin prodrugs. II: New method for synthesizing prostaglandin C1-aliphatic estersW Morozowich, T O Oesterling, W L Miller, et al.
Journal of Pharmaceutical Sciences|July 1, 1979
Prostaglandin prodrugs. I: Stabilization of dinoprostone (prostaglandin E2) in solid state through formation of crystalline C1-phenyl estersW Morozowich, T O Oesterling, W L Miller, et al.
Journal of Pharmaceutical Sciences|August 1, 1979
Prostaglandin prodrugs III: Synthesis and biological properties of C9- and C15-monoesters of dinoprost (prostaglandin F2 alpha)W Morozowich, T O Oesterling, W L Miller, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylateW J Adams, P A Aristoff, R K Jensen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Pharmaceutical Sciences|September 1, 1973
Detection of prostaglandin F2 alpha as pentafluorobenzyl ester by electron-capture GLCJ A Wickramasinghe, W Morozowich, W E Hamlin, et al.
Journal of Theoretical Biology|September 7, 1976
A physical model for the simultaneous membrane transport and metabolism of drugsN F Ho, J Park, W Morozowich, et al.
Journal of Pharmaceutical Sciences|July 1, 1979
Prostaglandin prodrugs. II: New method for synthesizing prostaglandin C1-aliphatic estersW Morozowich, T O Oesterling, W L Miller, et al.
Journal of Pharmaceutical Sciences|July 1, 1979
Prostaglandin prodrugs. I: Stabilization of dinoprostone (prostaglandin E2) in solid state through formation of crystalline C1-phenyl estersW Morozowich, T O Oesterling, W L Miller, et al.
Journal of Pharmaceutical Sciences|August 1, 1979
Prostaglandin prodrugs III: Synthesis and biological properties of C9- and C15-monoesters of dinoprost (prostaglandin F2 alpha)W Morozowich, T O Oesterling, W L Miller, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylateW J Adams, P A Aristoff, R K Jensen, et al.
Pageof 2